MARKET

NUS

NUS

Nu Skin Enter
NYSE

Real-time Quotes | Nasdaq Last Sale

46.11
+0.73
+1.61%
After Hours: 46.11 0 0.00% 16:02 05/27 EDT
OPEN
45.55
PREV CLOSE
45.38
HIGH
46.11
LOW
45.35
VOLUME
562.55K
TURNOVER
0
52 WEEK HIGH
62.70
52 WEEK LOW
38.43
MARKET CAP
4.63B
P/E (TTM)
17.12
1D
5D
1M
3M
1Y
5Y
Nu Skin Enterprises (NYSE:NUS) Is Due To Pay A Dividend Of US$0.39
Nu Skin Enterprises, Inc. ( NYSE:NUS ) will pay a dividend of US$0.39 on the 8th of June. The dividend yield will be...
Simply Wall St. · 2d ago
Insider Sell: Nu Skin Enterprises
MT Newswires · 05/18 17:47
Nu Skin Joins EcoBeautyScore Consortium to Drive Industry Standard for Sustainable Beauty Products
Nu Skin, a global leader in beauty and wellness, today announced its membership in the EcoBeautyScore Consortium; a globally recognized group developing an industry-wide environmental impact assessment and scoring system for cosmetics products.
PR Newswire · 05/17 20:05
Nu Skin Enterprises's Return On Capital Employed Insights
According to Benzinga Pro, during Q1, Nu Skin Enterprises (NYSE:NUS) earned $38.72 million, a 519.41% increase from the preceding quarter. Nu Skin Enterprises's sales decreased to $604.90 million, a 10.18% change since Q4.
Benzinga · 05/17 14:17
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be US$0.39
Nu Skin Enterprises, Inc. ( NYSE:NUS ) will pay a dividend of US$0.39 on the 8th of June. This means the annual payment...
Simply Wall St. · 05/12 10:14
--DA Davidson Adjusts Nu Skin Enterprises' Price Target to $45 from $50, Keeps Neutral Rating
MT Newswires · 05/05 13:26
Nu Skin Enterprises (NUS) Q1 Earnings and Revenues Top Estimates
Nu Skin (NUS) delivered earnings and revenue surprises of 4.11% and 4.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/04 23:05
Recap: Nu Skin Enterprises Q1 Earnings
Nu Skin Enterprises (NYSE:NUS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Nu Skin Enterprises beat estimated earnings by 5.56%, reporting an EPS of $0.76 versu...
Benzinga · 05/04 21:27
More
No Data
Learn about the latest financial forecast of NUS. Analyze the recent business situations of Nu Skin Enter through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

20.00%Strong Buy
20.00%Buy
60.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average NUS stock price target is 51.60 with a high estimate of 60.00 and a low estimate of 45.00.
High60.00
Average51.60
Low45.00
Current 46.11
EPS
Actual
Estimate
0.290.580.861.15
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 399
Institutional Holdings: 49.57M
% Owned: 49.36%
Shares Outstanding: 100.42M
TypeInstitutionsShares
Increased
79
3.69M
New
55
1.88M
Decreased
85
2.59M
Sold Out
42
1.10M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Personal Products
+2.24%
Personal & Household Products & Services
+2.20%
Key Executives
Chairman/Executive Director
Steven Lund
President/Chief Executive Officer/Director
Ryan Napierski
Chief Financial Officer/Executive Vice President
Mark Lawrence
Executive Vice President/Chief Scientific Officer
Joseph Chang
Executive Vice President/General Counsel
Chayce Clark
Executive Vice President
Steven Hatchett
Executive Vice President
Connie Tang
Lead Director/Independent Director
Daniel Campbell
Director
Emma Battle
Independent Director
Andrew Lipman
Independent Director
Laura Nathanson
Independent Director
Thomas Pisano
Independent Director
Zheqing Shen
Independent Director
Edwina Woodbury
No Data
No Data
About NUS
Nu Skin Enterprises, Inc. is a holding company. The Company through Nu Skin, a global direct selling company is engaged in developing and distributing personal care products and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products, which includes 180 System, AP 24, Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White, Tru Face and Sunright. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. Its ageLOC provides anti-aging products, which includes Facial Spa, Me, LumiSpa, TFEU and Transformation products. The Company operates through nine segments, which consists of seven geographic Nu Skin segments, including Mainland China, South Korea, Southeast Asia, Americas/Pacific, Hong Kong/Taiwan, Europe, Middle East and Africa (EMEA), and Japan. Its segments also include Manufacturing segment and Grow Tech segment.

Webull offers kinds of Nu Skin Enterprises, Inc. stock information, including NYSE:NUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NUS stock methods without spending real money on the virtual paper trading platform.